QAN
Qantas Airways Limited
🇦🇺 ASX
✈️ AIRLINES
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 4.93%
Annual Growth
5 years average annual growth
💰
4.99%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1,005
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
The company's long-term objective is to "build the Qantas Group's competitive advantages and create long-term shareholder value by maximising the strength of our integrated portfolio of businesses and brands."
📈 Performance
Price History
+393.45%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
4.99%
💰 Annual Dividend Earnings Per $1,000 invested**
$49.91
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
91.67 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of QAN, your last dividend payment(s) would have been:
$ 348.75
on Tue Sep 01 2020
$ 303.95
on Mon Sep 23 2019
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.25
100.00%
2018
$0.17
100.00%
2017
$0.14
0.00%
2016
$0.07
50.00%
2015
$0.00
0.00%
💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🍃 Environmental, Social and Governance scores ℹ️
🌳
Environmental Score
59
A measure of an organisations or investment's impact on the natural environment, including factors such as carbon emissions, resource usage, and pollution
⚖️
Governance Score
81
An evaluation of an organisations impact on society, focusing on factors such as employee welfare, diversity and inclusion, community engagement, and product safety and quality.
🤓 Advanced information
Technical Info
💰 Price*
$8.29
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in QAN
1,006
📊 Total Capital Earnings
$2M
🔃 Average investment frequency
43 weeks
💵 Average investment amount
$4,524
⏰ Last time a customer invested in QAN
7 hours
QAN investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
16%
50k - 100k
44%
Less than 50k
31%
👶 Age of investors
18 - 25
11%
26 - 34
45%
35 - 90
44%
🙋 Legal gender of investors
Female
63%
Male
37%
Pearlers who invest in QAN also invest in...
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.94%
📊 Share price
$101.26 AUD
🇦🇺 AUSTRALIA
💸 FINANCIALS
🧱 MATERIALS
⛳️ DIVERSIFIED
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
3.74%
📊 Share price
$66.59 AUD
⛳️ DIVERSIFIED
🌏 GLOBAL
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
12.93%
📊 Share price
$129.83 AUD
🤖 TECHNOLOGY
📈 HIGH PRICE GROWTH
🌏 GLOBAL
⛳️ DIVERSIFIED
IVV.AX was created on 2007-10-10 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of large capitalisation US equities.
🙌 Performance (5Yr p.a)
18.98%
📊 Share price
$57.91 AUD
📈 HIGH PRICE GROWTH
🇺🇸 UNITED STATES
A200.AX was created on 2018-05-07 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The ETF currently has 6138.42m in AUM and 200 holdings. A200.AX aims to track the performance of an index (before fees and expenses) comprising 200 of the largest companies by market capitalisation listed on the ASX.
🙌 Performance (5Yr p.a)
4.41%
📊 Share price
$136.46 AUD
💸 FINANCIALS
⛳️ DIVERSIFIED
Want more shares? Try these...
QAU.AX was created on 2011-05-03 by BetaShares. The fund's investment portfolio concentrates primarily on gold commodities. The investment objective of the Fund is to provide an investment return, before fees and expenses, that closely tracks the performance of the price of gold bullion, with a currency hedge against movements in the AUD/USD exchange rate.
🙌 Performance (5Yr p.a)
9.66%
📊 Share price
$22.66 AUD
📞 COMMUNICATIONS
📈 HIGH PRICE GROWTH
QBE Insurance Group Ltd. engages in providing underwriting general insurance and reinsurance risks. The company is headquartered in Sydney, New South Wales and currently employs 13,479 full-time employees. The principal activities of the Company include underwriting general insurance and reinsurance risks, management of Lloyd's syndicates and investment management. The firm's segments include North America, International and Australia Pacific. The North America segment writes general insurance, reinsurance, and crop business in the United States. The International segment writes general insurance business in the United Kingdom, Europe, and Canada. This segment also writes general insurance and reinsurance business through Lloyd's; worldwide reinsurance business through offices in the United Kingdom, United States, Ireland, Bermuda, Dubai, and mainland Europe; and provides personal and commercial insurance covers in Hong Kong, Singapore, Malaysia, and Vietnam. The Company’s Australia Pacific segment primarily underwrites general insurance risks throughout Australia, New Zealand and the Pacific region.
🙌 Performance (5Yr p.a)
6.93%
📊 Share price
$16.90 AUD
👩💼 INSURANCE
🌳 ENVIRONMENTAL
🕊️ SOCIALLY AWARE
🍃 HIGH ESG SCORE
PYC Therapeutics Ltd. is a drug-development company, which provides a new generation of RNA therapeutics to meet unmet need in disease. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2005-03-30. The firm utilizes its proprietary drug delivery platform to enhance the potency of precision medicines within the rapidly growing and commercially proven RNA therapeutic class. Its drug development programs target monogenic diseases - the indications with the highest likelihood of success in clinical development. Its first-in-class drug programs include Retinitis Pigmentosa type 11, (VP-001), Polycystic Kidney Disease, (PYC-003), Autosomal Dominant Optic Atrophy (ADOA) (PYC-001) and Phelan-McDermid Syndrome (PMS) (PYC-002). The firm's VP-001 program is a lead asset for a blinding eye disease of childhood progressed through multiple patient cohorts in the ongoing single ascending dose clinical trial. ADOA is a progressive and blinding eye disease.
🙌 Performance (5Yr p.a)
48.36%
📊 Share price
$0.19 AUD
📈 HIGH PRICE GROWTH
🧬 BIOTECHNOLOGY
Qualitas Ltd. engages in real estate management services. The company is headquartered in Melbourne, Victoria. The company went IPO on 2021-12-16. The firm offers a range of investment solutions for institutional, wholesale and retail clients. The company offers flexible capital solutions for its partners, creating long term value for shareholders and the communities in which it operates. The firm is focused on real estate private credit, opportunistic real estate private equity, income-producing commercial real estate and build-to-rent residential. The firm has two segments: Funds Management and Direct Lending. The Funds Management segment includes all the Company’s core funds management activities and includes funds management fees, performance fees and other fee income. The company also includes dividends and distributions from its co-investment and direct lending activities. The Direct Lending segment relates to the interest income and expenses relating to activities undertaken by its wholly owned subsidiaries Arch Finance and Peer Estate.
📊 Share price
$2.72 AUD
💸 FINANCIALS
🕊️
Social Score
65
An assessment of an organisations management practices, board structure, transparency, and accountability, reflecting its commitment to ethical behavior and responsible decision-making.